Literature DB >> 22561019

Evidence for clonal fibroblast proliferation and autoimmune process in idiopathic retroperitoneal fibrosis.

Jessica A Clevenger1, Mingsheng Wang, Gregory T MacLennan, Rodolfo Montironi, Antonio Lopez-Beltran, Liang Cheng.   

Abstract

Idiopathic retroperitoneal fibrosis is an uncommon disease characterized by encasement of retroperitoneal structures by fibrosis and chronic inflammation. Multiple etiologies have been proposed. First, we investigated if idiopathic retroperitoneal fibrosis is a clonal fibroblast proliferation by performing X-chromosome inactivation analyses. Second, we sought to determine if idiopathic retroperitoneal fibrosis is an autoimmune or immunoglobulin G4-driven process. Thirty cases of idiopathic retroperitoneal fibrosis, in whom known causes of retroperitoneal fibrosis were excluded and those for which paraffin blocks were available, were included in this study. We performed clonality analysis in 16 female patients. Genomic DNA samples were prepared from formalin-fixed, paraffin-embedded tissue sections using laser capture microdissection. Of the 16 cases, 15 were informative. Of 15 informative cases, 8 (53%) showed nonrandom X-chromosome inactivation or a clonal process. Of the 26 patients for which immunoglobulin G4 analysis was performed, 14 (54%) were positive for immunoglobulin G4-positive plasma cells, and all were negative for anaplastic lymphoma kinase. Of cases positive for immunoglobulin G4, the immunoglobulin G4:immunoglobulin G ratio ranged from 0.30 to 1.00 (mean, 0.80). Of the 12 patients for which both clonality analysis and immunoglobulin G4 analysis were performed, 4 (33%) were clonal and immunoglobulin G4 negative; 2 (17%), clonal and immunoglobulin G4 positive; 2 (17%), nonclonal and immunoglobulin G4 positive; and 4 (33%), nonclonal and immunoglobulin G4 negative. Our data indicate that a significant proportion (53%) of idiopathic retroperitoneal fibrosis cases in women is associated with a clonal expansion of fibroblasts. In addition, a subset of idiopathic retroperitoneal fibrosis cases could be classified in the immunoglobulin G4-related sclerosing disease spectrum.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22561019     DOI: 10.1016/j.humpath.2012.01.012

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  5 in total

1.  Idiopathic vs. secondary retroperitoneal fibrosis: a clinicopathological study of 12 cases, with emphasis to possible relationship to IgG4-related disease.

Authors:  Jan Laco; Miroslav Podhola; Kateřina Kamarádová; Ivo Novák; Daniel Dobeš; Miloš Broďák; Mária Hácová; Aleš Ryška
Journal:  Virchows Arch       Date:  2013-09-20       Impact factor: 4.064

2.  Elevated serum IgG4 levels in diagnosis and treatment response in patients with idiopathic retroperitoneal fibrosis.

Authors:  L G Pelkmans; T R Hendriksz; P J Westenend; H J Vermeer; E F H van Bommel
Journal:  Clin Rheumatol       Date:  2017-01-19       Impact factor: 2.980

Review 3.  Idiopathic Retroperitoneal Fibrosis.

Authors:  Augusto Vaglio; Federica Maritati
Journal:  J Am Soc Nephrol       Date:  2016-02-09       Impact factor: 10.121

4.  Non-Hodgkin lymphoma mimics retroperitoneal fibrosis.

Authors:  Ningxin Wan; Yang Jiao
Journal:  BMJ Case Rep       Date:  2013-08-06

5.  CD47 prevents the elimination of diseased fibroblasts in scleroderma.

Authors:  Tristan Lerbs; Lu Cui; Megan E King; Tim Chai; Claire Muscat; Lorinda Chung; Ryanne Brown; Kerri Rieger; Tyler Shibata; Gerlinde Wernig
Journal:  JCI Insight       Date:  2020-08-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.